IO Biotech (IOBT) Revenue & Revenue Breakdown
IO Biotech Revenue Highlights
00
IO Biotech Revenue by Period
IO Biotech Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | - |
IO Biotech Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $1.11M | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | - |
IO Biotech Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
HOWL | Werewolf Therapeutics | $19.94M | $1.14M |
IVA | Inventiva | $17.50M | $15.58M |
NAMS | NewAmsterdam Pharma Company | $14.09M | $2.13M |
IKNA | Ikena Oncology | $9.16M | - |
STOK | Stoke Therapeutics | $8.78M | $4.89M |
IPSC | Century Therapeutics | $2.23M | $791.00K |
STTK | Shattuck Labs | $1.66M | $1.61M |
LYRA | Lyra Therapeutics | $1.56M | $195.00K |
MNOV | MediciNova | $1.00M | - |
DSGN | Design Therapeutics | - | - |
CGEM | Cullinan Oncology | - | - |
GPCR | Structure Therapeutics | - | - |
PHVS | Pharvaris | - | - |
ERAS | Erasca | - | - |
IOBT | IO Biotech | - | - |
PMVP | PMV Pharmaceuticals | - | - |
GLUE | Monte Rosa Therapeutics | - | $4.70M |
CMPX | Compass Therapeutics | - | - |
PEPG | PepGen | - | - |
CSBR | Champions Oncology | - | $-14.06M |